Home » Topics » BioWorld Science

BioWorld Science
RSS

Apexigen and NSGO-CTU to collaborate on phase II study of sotigalimab for ovarian cancer

June 17, 2021

Interim phase IIb/III data on CVnCoV show statistical success criteria not met

June 17, 2021

CHN1 is a prognostic biomarker in DLBCL

June 17, 2021

Debiopharm and Ubix collaborate to develop antibody degraducer conjugates

June 17, 2021

Topline data from phase I study of NASH drug candidate ASC-42

June 17, 2021

Mydecine launches in silico drug discovery program with University of Alberta

June 17, 2021

DSMB recommends phase I trial of rhenium nanoliposomes in GBM proceed to next cohort

June 17, 2021

Phase I/II trial of eprenetapopt in TP53-mutant AML meets primary efficacy endpoint

June 17, 2021

Safety data presented for BGB-11417 in R/R B-cell malignancies

June 17, 2021

MacroGenics and Zai Lab collaborate on bispecific molecules in immuno-oncology

June 17, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...